Literature DB >> 12917262

OcaB regulates transitional B cell selection.

Mila Jankovic1, Michel C Nussenzweig.   

Abstract

OcaB, also known as Bob-1 or Obf-1, is a transcriptional co-activator which regulates Igkappa gene transcription, recombination and receptor editing; it is required for normal development of transitional B cells and for germinal center formation. Here we report that abnormal B cell development in OcaB(-/-) mice results in a skewed Igkappa repertoire including anti-DNA antibodies, suggesting that OcaB is essential for antibody repertoire selection. To determine whether OcaB is required for BCR-mediated B cell selection, we introduced a pre-recombined alpha hen egg lysozyme (HEL) Ig transgene into OcaB(-/-) mice. We find that in OcaB(-/-) mice expressing transgenic alphaHEL Ig bone marrow B cell development is normal up to the immature B cell stage, but fails to progress to the transitional B cell stage. We conclude that OcaB is required for normal selection of the antibody repertoire in developing B cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12917262     DOI: 10.1093/intimm/dxg109

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  10 in total

1.  A multifunctional element in the mouse Igκ locus that specifies repertoire and Ig loci subnuclear location.

Authors:  Yougui Xiang; Xiaorong Zhou; Susannah L Hewitt; Jane A Skok; William T Garrard
Journal:  J Immunol       Date:  2011-03-25       Impact factor: 5.422

2.  A major deletion in the Vκ-Jκ intervening region results in hyperelevated transcription of proximal Vκ genes and a severely restricted repertoire.

Authors:  Yougui Xiang; Sung-Kyun Park; William T Garrard
Journal:  J Immunol       Date:  2014-09-03       Impact factor: 5.422

3.  Vκ gene repertoire and locus contraction are specified by critical DNase I hypersensitive sites within the Vκ-Jκ intervening region.

Authors:  Yougui Xiang; Sung-Kyun Park; William T Garrard
Journal:  J Immunol       Date:  2013-01-07       Impact factor: 5.422

4.  Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner.

Authors:  Priyadarshini Chatterjee; Amma F Agyemang; Marat B Alimzhanov; Soren Degn; Stefanos A Tsiftsoglou; Elisabeth Alicot; Sarah A Jones; Minghe Ma; Michael C Carroll
Journal:  Eur J Immunol       Date:  2013-07-03       Impact factor: 5.532

5.  The Ets factor Spi-B is a direct critical target of the coactivator OBF-1.

Authors:  Boris Bartholdy; Camille Du Roure; Alain Bordon; Dianne Emslie; Lynn M Corcoran; Patrick Matthias
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-21       Impact factor: 11.205

6.  Oct2 and Obf1 as Facilitators of B:T Cell Collaboration during a Humoral Immune Response.

Authors:  Lynn Corcoran; Dianne Emslie; Tobias Kratina; Wei Shi; Susanne Hirsch; Nadine Taubenheim; Stephane Chevrier
Journal:  Front Immunol       Date:  2014-03-20       Impact factor: 7.561

7.  Genetic architecture of early pre-inflammatory stage transcription signatures of autoimmune diabetes in the pancreatic lymph nodes of the NOD mouse reveals significant gene enrichment on chromosomes 6 and 7.

Authors:  Beatrice Regnault; Evie Melanitou
Journal:  Meta Gene       Date:  2015-10-22

Review 8.  Fatty acids - from energy substrates to key regulators of cell survival, proliferation and effector function.

Authors:  Danilo Cucchi; Dolores Camacho-Muñoz; Michelangelo Certo; Valentina Pucino; Anna Nicolaou; Claudio Mauro
Journal:  Cell Stress       Date:  2019-12-10

9.  Co-modulation of T cells and B cells enhances the inhibition of inflammation in experimental hypersensitivity pneumonitis.

Authors:  Olivier Courtemanche; Carole-Ann Huppé; Pascale Blais Lecours; Ophélie Lerdu; Joanny Roy; Jean-François Lauzon-Joset; Marie-Renée Blanchet; Mathieu C Morissette; David Marsolais
Journal:  Respir Res       Date:  2022-10-08

10.  Enforced expression of the transcriptional coactivator OBF1 impairs B cell differentiation at the earliest stage of development.

Authors:  Alain Bordon; Nabil Bosco; Camille Du Roure; Boris Bartholdy; Hubertus Kohler; Gabriele Matthias; Antonius G Rolink; Patrick Matthias
Journal:  PLoS One       Date:  2008-12-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.